Hermetica Superfood Encyclopedia
The Short Answer
Banisteriopsis caapi is a South American vine containing harmala alkaloids like harmine and harmaline. These compounds primarily act as reversible monoamine oxidase-A (MAO-A) inhibitors, modulating neurotransmitter levels.
CategoryHerbs (Global Traditional)
GroupAmazonian
Evidence LevelModerate
Primary KeywordBanisteriopsis caapi benefits
Synergy Pairings3
Banisteriopsis caapi — botanical close-up
Health Benefits
Origin & History
Natural habitat
Banisteriopsis caapi is a woody vine native to the Amazon rainforest in South America, belonging to the Malpighiaceae family, primarily used in traditional preparations like ayahuasca. The source organism is the stem bark of the plant, with extracts typically prepared by decoction (boiling) in water, yielding a crude extract containing beta-carboline alkaloids including harmine, harmaline, and tetrahydroharmine.
“Banisteriopsis caapi has been used for centuries in Amazonian indigenous traditional medicine systems, particularly by groups like the Awajún, as a primary ingredient in ayahuasca for spiritual initiation rites, healing, and visionary purposes. Historical use dates to pre-Columbian times in the western Amazon, often combined with Psychotria viridis for entheogenic brews.”Traditional Medicine
Scientific Research
Clinical evidence is extremely limited, consisting only of historical case series from the 1920s at Neukoelln Hospital using subcutaneous banisterine (25-70mg) for postencephalitic parkinsonism, and one referenced trial with 30 de novo Parkinson's patients (15 receiving 200mL oral extract), though no PMIDs or controlled study designs are available. Modern research is restricted to in vitro studies using SH-SY5Y neuroblastoma and BV-2 microglial cell lines.
Preparation & Dosage
Traditional preparation
Historical clinical use: 25-70mg banisterine (harmine) subcutaneously for neurological conditions; 200mL oral B. caapi extract for Parkinson's patients (non-standardized). In vitro studies used 0.1% extract concentration or harmine at 3-30μM. No standardized dosages or modern clinical recommendations exist. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Banisteriopsis caapi vine bark and stems contain negligible macronutrient value as a dietary source; it is consumed primarily as a medicinal/ceremonial preparation rather than a food. Bioactive alkaloid content is the primary area of characterization: beta-carboline alkaloids dominate the profile, with harmine typically present at 0.2–4.0% dry weight (most concentrated compound), harmaline at 0.03–0.5% dry weight, and tetrahydroharmine (THH) at 0.05–0.4% dry weight; concentrations vary significantly by plant age, geographic origin, and preparation method. Trace alkaloids including harmol, harmalol, and norharmine are detected in smaller quantities (<0.05% dry weight). Tannins and procyanidins are present in the bark at moderate concentrations (estimated 2–8% dry weight), contributing astringency. Phenolic acids including caffeic acid and ferulic acid derivatives have been identified via HPLC analysis in aqueous extracts. Saponins are present at low levels. Conventional micronutrients (vitamins B, C, E; minerals such as magnesium, potassium, calcium) are present only in trace amounts typical of woody plant material and contribute no meaningful nutritional value at ceremonial doses (typically 50–150g fresh vine per preparation). Bioavailability note: harmine and harmaline are orally bioavailable; harmaline is rapidly reduced to THH in vivo; beta-carbolines act as reversible MAO-A inhibitors, which directly affects bioavailability of co-administered tryptamines in ayahuasca preparations. Fiber content exists as structural lignocellulosic material but is not nutritionally relevant in decoction-based preparations.
How It Works
Mechanism of Action
Banisteriopsis caapi's primary active compounds, harmine and harmaline, reversibly inhibit monoamine oxidase-A (MAO-A). This enzymatic inhibition prevents the breakdown of monoamine neurotransmitters such as serotonin, dopamine, and norepinephrine, increasing their synaptic availability. Additionally, tetrahydroharmine acts as a weak selective serotonin reuptake inhibitor (SSRI), further influencing serotonin signaling.
Clinical Evidence
Historical case series from the 1920s suggested Banisteriopsis caapi's potential for neurological support, though these lacked modern controlled trial rigor or quantitative outcomes. Current human evidence for its benefits is extremely limited, with no large-scale clinical studies confirming its traditional uses. In vitro cell studies demonstrate anti-inflammatory effects by reducing pro-inflammatory cytokines like IL-6, but these findings have not been replicated in living organisms or human trials.
Safety & Interactions
Due to its MAO-inhibiting properties, Banisteriopsis caapi poses significant risks for interactions. It should not be combined with SSRIs, SNRIs, tricyclic antidepressants, or other MAOIs, as this can lead to serotonin syndrome. Interactions with tyramine-rich foods (aged cheeses, cured meats) can cause hypertensive crisis. Common side effects include nausea, vomiting, and diarrhea. It is contraindicated in individuals with cardiovascular conditions, liver disease, or certain mental health disorders, and its use is strongly discouraged during pregnancy and breastfeeding.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Banisteriopsis caapiAyahuasca vineYageCaapiSoul vineVine of the deadBanisteria caapi
Frequently Asked Questions
What is Banisteriopsis caapi?
Banisteriopsis caapi is a woody vine native to the Amazon rainforest, historically revered by indigenous cultures. It is a principal ingredient in the traditional ceremonial brew ayahuasca, valued for its complex psychoactive properties.
What are the primary active compounds in Banisteriopsis caapi?
The main active compounds in Banisteriopsis caapi are harmala alkaloids, including harmine, harmaline, and tetrahydroharmine. These compounds are responsible for the vine's significant pharmacological effects, particularly its MAO-inhibiting activity.
How does Banisteriopsis caapi influence brain function?
Banisteriopsis caapi primarily influences brain function through its harmala alkaloids, which act as reversible monoamine oxidase-A (MAO-A) inhibitors. This mechanism increases the synaptic concentrations of neurotransmitters like serotonin, dopamine, and norepinephrine, potentially affecting mood, cognition, and perception.
What are the potential side effects associated with Banisteriopsis caapi?
Potential side effects of Banisteriopsis caapi commonly include gastrointestinal upset such as nausea, vomiting, and diarrhea, particularly at higher doses. Due to its MAOI activity, it can also lead to more serious effects like changes in blood pressure or heart rate, especially when improperly used or combined with other substances.
Can Banisteriopsis caapi be safely combined with other medications or supplements?
No, Banisteriopsis caapi should not be combined with most medications, especially antidepressants (SSRIs, SNRIs, TCAs) or other MAOIs, due to a high risk of severe serotonin syndrome or hypertensive crisis. It also interacts with tyramine-rich foods and certain supplements, making medical consultation imperative before use.
What does the research evidence show about Banisteriopsis caapi's effectiveness?
Most evidence for Banisteriopsis caapi comes from in vitro cell studies and historical case reports rather than controlled human clinical trials. While laboratory studies suggest potential anti-inflammatory and immune-modulating effects through cytokine reduction, these findings have not been replicated in rigorous human studies. The neurological support claims are based primarily on anecdotal historical reports from the 1920s without modern scientific validation. More controlled research is needed to establish efficacy and safety profiles in human populations.
Who should avoid Banisteriopsis caapi due to safety concerns?
Individuals taking monoamine oxidase inhibitor (MAOI) medications, serotonergic drugs, or stimulants should avoid Banisteriopsis caapi due to serious interaction risks. Pregnant and nursing women should not use this ingredient as safety data is insufficient. People with uncontrolled hypertension, heart conditions, or psychiatric disorders should consult a healthcare provider before use, as the ingredient's psychoactive properties and MAO-inhibiting mechanism carry potential risks in these populations.
How is Banisteriopsis caapi typically prepared and does preparation method affect its activity?
Banisteriopsis caapi is traditionally prepared as a decoction or brew, often combined with other plant materials in traditional Amazonian preparations, though the role of combination effects is not well-characterized scientifically. The preparation method may influence alkaloid extraction and bioavailability, but standardized extraction research comparing different preparation techniques is limited. Commercial supplements vary widely in form (powders, extracts, tinctures) without consistent standardization of active compound content or established optimal preparation protocols.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w banisteriopsis-caapi curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
